Deals channel feed – Endpoints News

Deals channel feed

Playboy, digital health, electric vehicles and now cancer drugs: A mountainous SPAC journey

3 years ago

AbbVie recruits a GPCR team in Oxford, buying out a fledgling biotech for $255M+

3 years ago

Takeda adds one more late-stage treatment to its growing roster of celiac drugs

3 years ago

Two public biotechs seek to merge, focusing on desmoid tumors. But Nasdaq is not guaranteed

3 years ago

Can a little startup equipped with an Eli Lilly castoff make it big with an oncology IPO? In 2022?

3 years ago

Updated: Zymeworks wanted a Big Pharma partner for its bispecific. Jazz Pharmaceuticals said OK

3 years ago

Exclusive: Struggling Editas shops preclinical cancer pipeline during its big makeover

3 years ago

Updated: Not known for gene therapy plays, Eli Lilly acquires hearing loss startup Akouos for $487M plus CVR

3 years ago

Korean buyer jumps into M&A game with $566M bid for Aveo Oncology

3 years ago

GSK expands AI partnership with Tempus, fronting $70M for access to 'multimodal data'

3 years ago

Gilead calls dibs on a PhI bispecific, hands over $60M to cash-strapped MacroGenics

3 years ago

Six biotechs merge to take on BridgeBio, Abeona in 'butterfly skin' disease, with eyes also set on Duchenne

3 years ago

Imara puts an end to its struggles as OrbiMed, 5AM-backed precision oncology player rides the shell to Nasdaq

3 years ago

Updated: BridgeBio's $2.4B partnership takes a sudden hit as Helsinn plans to withdraw NDA on FGFR2 drug

3 years ago

Amid a global buildout, Cytiva acquires a provider of viral vector manufacturing technologies

3 years ago

Viatris weighs sale of European consumer health business — report

3 years ago

Merck pays Moderna $250M to continue Keytruda, cancer vaccine combo studies

3 years ago

Royalty Pharma bets Merck's schizophrenia drug can go where Pfizer, Takeda and Lundbeck's couldn’t

3 years ago

Months after adding $60M to coffers, AI startup Terray nabs discovery pact with Google's Calico

3 years ago

‘Pluck those diamonds’: Bayer’s Vividion eyes up to nine oncology targets from Duke spinout

3 years ago

Now bankrupt, Zosano sells off its drug delivery tech that once enticed Novo Nordisk, Eli Lilly

3 years ago

Pfizer exec denies vaccine negotiations via text message in grilling before European Parliament

3 years ago

Eli Lilly tasks Nimbus with hitting a 'high-value' target for diabetes, obesity

3 years ago

Illumina continues trek into drug discovery, inks AI pact with AstraZeneca

3 years ago

First page Previous page 49 50 515253 54 55 Next page Last page